Death and dependence: current controversies over the selective serotonin reuptake inhibitors (Q35660695)

9 August 2017

title

Death and dependence: current controversies over the selective serotonin reuptake inhibitors (English)

1 reference

9 August 2017

1

David J Nutt

0 references

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Journal of Psychopharmacology

9 August 2017

published in

1 reference

9 August 2017

volume

17

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

355-364

1 reference

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Tryptophan depletion and its implications for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

SSRI discontinuation syndrome treated with fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Monoamine depletion in unmedicated depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Withdrawal reaction after long-term therapeutic use of benzodiazepines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Serotonin reuptake inhibitor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Abstinence symptoms after withdrawal of tranquillising drugs: is there a common neurochemical mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Suicide in the 18 years after deliberate self-harm a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Testing the abuse liability of anxiolytic and hypnotic drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Acute tryptophan depletion in healthy young women with a family history of major affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Prolonged use of oral contraception before a planned pregnancy is associated with a decreased risk of delayed conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Tricyclic antidepressant withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

The SSRI discontinuation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Do antidepressants have any potential to cause addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Suicide as an outcome for mental disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Emergence of antidepressant induced suicidality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

SSRIs and deliberate self-harm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Pharmacological stress diathesis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Suicide in the course of the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Epidemiology and relative toxicity of antidepressant drugs in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Factors predicting long-term outcome after chronic benzodiazepine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

The utilization of antidepressants--a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Antidepressants and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

m-Chlorophenylpiperazine as a probe of serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Strategies for preventing suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Neurobiology of addiction and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Antidepressants and suicide risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Benzodiazepine dependence in the clinic: reason for anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Second-order schedules of drug self-administration in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Long-term Therapeutic Use of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Multiple recurrences of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Neuroleptic discontinuation syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Gradual withdrawal of diazepam after long-term therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Drug effects on REM sleep and on endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881103174019

21 January 2018

Identifiers

DOI

10.1177/0269881103174019

1 reference

9 August 2017

1 reference